TrialEuropean urology oncology2024

Long-term Outcomes of Chemoradiation for Muscle-invasive Bladder Cancer in Noncystectomy Candidates. Final Results of NRG Oncology RTOG 0524-A Phase 1/2 Trial of Paclitaxel + Trastuzumab with Daily Radiation or Paclitaxel Alone with Daily Irradiation.

Douglas M Dahl et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.